Leaders in Biomanufacturing Webinar Series

Capacity and Productivity in Biopharmaceutical Production (US)

Americas: September 20 11:00AM Pacific, 2:00PM Eastern

This webinar focuses on key results from the 9th annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production. The report surveys 302 individuals at biotherapeutic developers and CMOs in 29 countries worldwide, plus 186 industry vendors to determine key industry trends. The report is unquestionably the most comprehensive in the industry and shows year-by-year snapshots of changing perspectives around capacity in the last decade at the world's leading biomanufacturers.

This year's report highlights a number of emerging trends in the industry: biogenerics manufacturing, a resurgence of interest in capacity investment, and a focus on higher titers. Our two panelists, Eric Langer of BioPlan Associates and Rick Johnston, Ph.D. from Bio-G will examine some of these trends as well as reporting on current and potential areas of focus in the next 5-10 years for biomanufacturers and CMOs.

In this session we will examine:

- Trends in Approvals and their impact on capacity utilization
- Current Capacity Constraints and perceived bottlenecks
- An assessment of current productivity as well as future technologies
- Factors affecting biomanufacturing performance in developers vs. CMOs
- Expected capacity constraints over the next 5 years
- How future capacity expansions are expected to address these constraints

For more information on the report, click here.

Register for this free webinar (spaces limited):

Panelists

Eric Langer
Eric Langer (elanger@bioplanassociates.com) is President and Managing Partner and President of BioPlan Associates, a biotechnology and life sciences consulting company that has been providing management and market strategy services, and technology analysis to biopharmaceutical and healthcare organizations since 1989. He has over 20 years experience in biotechnology and life sciences management and market assessment. He is an experienced medical and biotechnology industry pracititioner, strategist, researcher, and science writer.

Rick Johnston, Ph.D.
Dr. Rick Johnston (rick@bio-g.com) is Founder and CEO of Bioproduction Group. In this role he helps biopharmaceutical manufacturers make better decisions in the areas of risk, uncertainty, biomanufacturing capacity, technology transfer, data / process control, and economic analysis. Dr. Johnston is Executive Director of the University of California at Berkeley's CELDi Center for Research in Biopharmaceutical Operations, and an Adjunct Professor at Keck Graduate Institute, part of the Claremont Colleges in California.